Clinical Commissioning Policy: Robotic assisted surgery for oesophago-gastric cancers

Evidence Review: Robotic assisted surgery for oesophago-gastric cancers FOR PUBLIC CONSULTATION ONLY

Standard Operating Procedure: Clinical Commissioning Policy: Robotic assisted surgery for early kidney cancers that are unsuitable for conventional laparoscopic surgery

[Oesophago-gastric cancer and minimally invasive surgery].

Oesophago-gastric cancer is the fifth most common type of malignancy and the fourth most frequent cause of death in the United Kingdom, affecting 13 500 people every year. Numerous epidemiological studies have shown that its incidence, particularly at the oesophago-gastric junction, has increased in recent years. The prognosis for this type of cancer is poor, with 5-year survival rates being ap...

Simultaneous robotic subtotal gastrectomy and right hemicolectomy for synchronous adenocarcinoma of stomach and colon

Simultaneous laparoscopy-assisted resection for synchronous stomach and colon cancers has been reported frequently; however, robot-assisted gastrectomy and colectomy for these conditions are rarely reported. We report the successful use of robotic surgery for synchronous cancers of the stomach and colon. A 71-year-old woman with no specific medical history was diagnosed with early gastric cance...

Current status of robotic surgery in Japan

The da Vinci S surgical system (Intuitive Surgical) was approved as a medical device in 2009 by the Japanese Ministry of Health, Labour and Welfare. Robotic surgery has since been used in gastrointestinal, thoracic, gynecological, and urological surgeries. In April 2012, robotic-assisted laparoscopic radical prostatectomy (RALP) was first approved for insurance coverage. Since then, RALP has be...